Cyntellect Names Zarrabian as CEO

Xconomy San Diego — 

San Diego-based Cyntellect, a privately held biotech commercializing products for life sciences, stem cell research, drug discovery, and biopharmaceutical production, today named Saiid Zarrabian as president and CEO. He replaces co-founder Fred Koller, who is taking over as Cyntellect’s chief technology officer. Zarrabian, who has been consulting with Cyntellect since March, was previously COO at San Diego-based Senomyx (NASDAQ: [[ticker:SNMX) and Pharmacopeia.